{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T20:01:24Z","timestamp":1782590484588,"version":"3.54.5"},"reference-count":0,"publisher":"OAE Publishing Inc.","content-domain":{"domain":["oaepublish.com"],"crossmark-restriction":true},"short-container-title":["CDR"],"DOI":"10.20517\/cdr.2019.66","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T06:54:37Z","timestamp":1573800877000},"update-policy":"https:\/\/doi.org\/10.20517\/oae.crossmark.policy","source":"Crossref","is-referenced-by-count":9,"title":["RET in breast cancer: pathogenic implications and mechanisms of drug resistance"],"prefix":"10.20517","author":[{"given":"Cristiana","family":"Lo Nigro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Rusmini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Ceccherini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8410","published-online":{"date-parts":[[2019]]},"container-title":["Cancer  Drug Resistance"],"original-title":[],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T08:43:18Z","timestamp":1705567398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oaepublish.com\/articles\/cdr.2019.66"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":0,"URL":"https:\/\/doi.org\/10.20517\/cdr.2019.66","relation":{},"subject":[],"published":{"date-parts":[[2019]]}}}